HOVR Q1 2026 Earnings WiderThanExpected Loss as Development Continues Stock Surges Over 26 VMC Q1 2026 Earnings Strong EPS Beat Driven by Pricing and Cost Control BW Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline TRP Q1 2026 Earnings A Slight Earnings Miss Against NearExpected Results NFE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises 575 Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development